Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in April 2009
*Drugs may be covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
| ACIPHEX | Eisai Medcl Res | rabeprazole sodium | 5,035,899 | Apr 4, 2009 |
| CASODEX | Astrazeneca | bicalutamide | 4,636,505 | Apr 1, 2009 |
| GENESA | Gensia Automedics | arbutamine hydrochloride | 5,108,363 | Apr 28, 2009 |
| MALARONE | Glaxosmithkline | atovaquone; proguanil hydrochloride | 5,053,432 | Apr 1, 2009 |
| MALARONE PEDIATRIC | Glaxosmithkline | atovaquone; proguanil hydrochloride | 5,053,432 | Apr 1, 2009 |
| MEPRON | Glaxosmithkline | atovaquone | 5,053,432 | Apr 1, 2009 |
| PREFEST | Duramed | estradiol; norgestimate | 5,108,995 | Apr 28, 2009 |
| SKELID | Sanofi Aventis Us | tiludronate disodium | 4,980,171 | Apr 6, 2009 |
| SPECTRACEF | Cornerstone | cefditoren pivoxil | 4,839,350 | Apr 14, 2009 |
| UVADEX | Therakos | methoxsalen | 4,845,075 | Apr 11, 2009 |
Courtesy of DrugPatentWatch.com
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

![[Bloglines]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/bloglines.png)
![[del.icio.us]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/delicious.png)
![[Digg]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/digg.png)
![[Facebook]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/facebook.png)
![[Google]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/google.png)
![[LinkedIn]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Reddit]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/reddit.png)
![[StumbleUpon]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/stumbleupon.png)
![[Twitter]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/twitter.png)
![[Email]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/email.png)








































